Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Falling between the cracks: a case of amiodarone toxicity.

Literature DB >> 21746823

Falling between the cracks: a case of amiodarone toxicity.

Constanze Mackenzie¹, Jaffer Syed, P Timothy Pollak, Gideon Koren.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2011 PMID： 21746823 PMCID： PMC3168627 DOI： 10.1503/cmaj.100351

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

15 in total

Review 1. Mechanisms underlying variability in response to drug therapy: implications for amiodarone use.

Authors: D M Roden
Journal: Am J Cardiol Date: 1999-11-04 Impact factor: 2.778

2. Amiodarone-induced thyroid dysfunction associated with cumulative dose.

Authors: Marcel L Bouvy; Eibert R Heerdink; Arno W Hoes; Hubert G M Leufkens
Journal: Pharmacoepidemiol Drug Saf Date: 2002 Oct-Nov Impact factor: 2.890

3. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors: Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal: Circulation Date: 2006-08-15 Impact factor: 29.690

4. Adherence to the NASPE guideline for amiodarone monitoring at a medical university.

Authors: Courtney L Bickford; Anne P Spencer
Journal: J Manag Care Pharm Date: 2006-04

5. Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II).

Authors: Jason G Andrade; Stuart J Connolly; Paul Dorian; Martin Green; Karin H Humphries; George J Klein; Robert Sheldon; Mario Talajic; Charles R Kerr
Journal: Heart Rhythm Date: 2010-04-27 Impact factor: 6.343

Review 6. Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions.

Authors: Dante Antonelli; Shaul Atar; Nahum A Freedberg; Tiberio Rosenfeld
Journal: Isr Med Assoc J Date: 2005-03 Impact factor: 0.892

7. Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice.

Authors: Yen-Fu Chen; Anthony J Avery; Karen E Neil; Christine Johnson; Michael E Dewey; Ivan H Stockley
Journal: Drug Saf Date: 2005 Impact factor: 5.606

3. The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.

Authors: In Sook Kang; Kyung Jin Kim; Yookyung Kim; Seong-Hoon Park
Journal: Korean J Intern Med Date: 2014-10-31 Impact factor: 2.884

3 in total

Falling between the cracks: a case of amiodarone toxicity.

Review 1. Mechanisms underlying variability in response to drug therapy: implications for amiodarone use.

2. Amiodarone-induced thyroid dysfunction associated with cumulative dose.

4. Adherence to the NASPE guideline for amiodarone monitoring at a medical university.

5. Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II).

Review 6. Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions.

7. Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice.

8. A practical guide for clinicians who treat patients with amiodarone: 2007.

9. Pulmonary toxicity in patients receiving low-dose amiodarone.

10. Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice.

1. Amiodarone-related thyroid dysfunction.

2. Acute amiodarone pulmonary toxicity following lung resection.

3. The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.